<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2026-01-23 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2026-01-23/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2026-01-23"><meta property="og:description" content="ğŸ“… Daily Report - 2026-01-23 ä»Šæ—¥ç­›é€‰å‡º 76 æ¡å†…å®¹ï¼Œæ¥è‡ª 1 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2026-01-23T00:00:00+00:00"><meta property="article:modified_time" content="2026-01-23T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week042026"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2026-01-23"><meta itemprop=description content="ğŸ“… Daily Report - 2026-01-23 ä»Šæ—¥ç­›é€‰å‡º 76 æ¡å†…å®¹ï¼Œæ¥è‡ª 1 ä¸ªæ¥æº"><meta itemprop=datePublished content="2026-01-23T00:00:00+00:00"><meta itemprop=dateModified content="2026-01-23T00:00:00+00:00"><meta itemprop=wordCount content="2354"><meta itemprop=keywords content="Research,Daily,Week042026"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2026-01-23"><meta name=twitter:description content="ğŸ“… Daily Report - 2026-01-23 ä»Šæ—¥ç­›é€‰å‡º 76 æ¡å†…å®¹ï¼Œæ¥è‡ª 1 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-23</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2026-01-23T00:00:00Z>2026-01-23</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2026-01-23>ğŸ“… Daily Report - 2026-01-23</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>76</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>1</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
METTL14åœ¨Krasè¯±å¯¼çš„é«“å•æ ¸ç»†èƒç™½è¡€ç—…å‘ç”Ÿä¸­è°ƒæ§è‡ªå™¬ï¼Œä»¥åŠEGR1è°ƒæ§CSF1RåŸºå› ç»„ç»“æ„çš„æ–°å‘ç°ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>ç™Œç—‡å‘ç”Ÿä¸è¿›å±•æœºåˆ¶ï¼šæ¶‰åŠm6Aä¿®é¥°ï¼ˆMETTL14ï¼‰ã€ä¿¡å·é€šè·¯ï¼ˆEZH2/E2F1ã€ATF4ï¼‰ã€åŸºå› ç»„è°ƒæ§ï¼ˆEGR1ï¼‰ä»¥åŠlncRNAï¼ˆIGF1R-AS1ï¼‰åœ¨ç™½è¡€ç—…ã€ä¹³è…ºç™Œã€è‚ç™Œã€èƒ¶è´¨æ¯ç»†èƒç˜¤ç­‰ç™Œç—‡ä¸­çš„ä½œç”¨ã€‚</li><li>å…ç–«ç»†èƒåŠŸèƒ½ä¸è°ƒæ§ï¼šç ”ç©¶å…ç–«ç»†èƒï¼ˆæ ‘çªçŠ¶ç»†èƒã€Î³Î´ Tç»†èƒã€CD8+ Tç»†èƒï¼‰åœ¨æŠ—è‚¿ç˜¤å…ç–«ã€ç»„ç»‡ç›‘è§†åŠSARS-CoV-2æ„ŸæŸ“ä¸­çš„ä½œç”¨ï¼Œä»¥åŠçº³ç±³é¢—ç²’å¯¹å…ç–«ç»†èƒåŠŸèƒ½çš„è¯±å¯¼ã€‚</li><li>ä»£è°¢ä¸ç–¾ç—…ï¼šæ¢è®¨çº¿ç²’ä½“ä»£è°¢å¯¹æ ‘çªçŠ¶ç»†èƒåŠŸèƒ½çš„å½±å“ï¼Œä»¥åŠè„‚è‚ªè‚å‘è‚ç™Œè½¬åŒ–çš„æœºåˆ¶ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>å¤šç»„å­¦è”åˆåˆ†æï¼šç»“åˆRNA-seqã€ATAC-seqã€ChIP-seqã€Hi-Cç­‰æŠ€æœ¯ï¼Œæ·±å…¥è§£æåŸºå› è¡¨è¾¾ã€æŸ“è‰²è´¨å¯åŠæ€§ã€è½¬å½•å› å­ç»“åˆåŠåŸºå› ç»„ä¸‰ç»´ç»“æ„ã€‚</li><li>å•ç»†èƒæµ‹åºï¼ˆscRNA-seqï¼‰ï¼šåº”ç”¨äºå…ç–«ç»†èƒã€CAR Tç»†èƒåŠè‚è„ç–¾ç—…ç ”ç©¶ï¼Œæ­ç¤ºç»†èƒå¼‚è´¨æ€§åŠå¾®ç¯å¢ƒè°ƒæ§ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (76æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE298142 m6A ç”²åŸºè½¬ç§»é…¶ METTL14 é€šè¿‡å¤±è°ƒè‡ªå™¬ä¿ƒè¿›è‡´ç™Œ Kras è¯±å¯¼çš„å¹¼å¹´éª¨é«“å•æ ¸ç»†èƒç™½è¡€ç—… [RNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€regex:onco(logy|logist|gene|genic)ã€RNA-seqã€KRAS</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Guangyao Kong ; Peihua ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe M6A modification plays an important role in the pathogenesis of various myeloid malignancies. However, its specific role in RAS mutant-induced myeloid malignancy is incompletely understood. In this study, we found that m6A methyltransferase METTL14 was highly expressed and associated with a shorter survival in a RAS-mutant myeloid malignancy, juvenile myelomonocytic leukemia (JMML). The knockout of METTL14 was revealed to significantly promote hematopoietic stem/progenitor cells (HSPCs) expansion and suppresses disease progression in a KrasG12D/+ mutant-induced mouse model of JMML. Moreover, knockout of METTL14 reduces hyperproliferation of KrasG12D/+ HSPCs and suppresses oncogenic KrasG12D/+-induced myeloid disease in a cell-autonomous manner. Mechanistically, we revealed that the knockout of METTL14 reduced the autophagy levels of HSPCs by suppressing the transcription and translation of autophagy-related genes, such as Atg5 and Atg9a, through m6A modification. Furthermore, we found that the autophagy inhibition through knockout of ATG5 in Kras mutant mice promoted the expansion of HSPCs and inhibited the progression of leukemia disease, consistent with the phenotypes of knockout of METTL14. Finally, we observed that combined treatment with an m6A inhibitor and a MEK inhibitor synergistically suppressed JMML growth. Collectively, these findings highlight the critical role of METTL14 in JMML tumorigenesis and suggest that m6A RNA modification represents a promising therapeutic target for this disease.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298142">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE311097 å¤–å‘¨SARS-CoV-2æ„ŸæŸ“åå°é¼ è„‘å…ç–«ç»†èƒçš„å•ç»†èƒRNAæµ‹åº</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€sequencingã€single-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Lu Tan ; Shea Lowery ; Andrew Thurman ; Stanley PerlmanSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusNeurological and neuropsychiatric symptoms are among the most prevalent Post-Acute Sequelae of COVID-19 (PASC), collectively referred to as neuroPASC. Despite growing recognition, the mechanisms driving neuroPASC remain elusive, hindering therapeutic development. Brain immune cells - particularly microglia - have been implicated, yet current knowledge largely derives from post-mortem tissues with variable disease courses and comorbidities and limited spatial coverage. To address this, we established a PASC animal model by infecting C57BL/6 mice with a sublethal dose of mouse-adapted SARS-CoV-2. Infected mice exhibited persistent behavioural alterations and prolonged neuroinflammation in the absence of direct viral neuroinvasion. Single-cell RNA sequencing of brain immune cells collected at 0, 6, 30, and 100 days post-infection (dpi) revealed underlying dynamic, longitudinal immune responses. Microglia, the predominant brain-resident sentinel cells, displayed sustained expansion of subclusters characterized by inflammatory, stress response, and metabolic reprogramming signatures across all time points. Border-associated macrophages upregulated monocyte attractants during acute infection and were partially replaced by infiltrating monocytes. Concurrently, inflammatory monocytes and neutrophils showed maximal brain infiltration and antiviral activity at 6 dpi, potentially triggering long-term microglial activation. Together, these findings provide a high-resolution atlas of brain myeloid immune dynamics during neuroPASC and highlight a central role of microglia in sustaining chronic neuroinflammation, offering insight into potential therapeutic targets.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311097">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE298134 m6Aç”²åŸºè½¬ç§»é…¶METTL14é€šè¿‡è‡ªå™¬å¤±è°ƒä¿ƒè¿›è‡´ç™ŒKrasè¯±å¯¼çš„å¹¼å¹´å‹éª¨é«“å•æ ¸ç»†èƒç™½è¡€ç—…</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€regex:onco(logy|logist|gene|genic)ã€KRAS</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Guangyao Kong ; Peihua ZhangSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Mus musculusThe M6A modification plays an important role in the pathogenesis of various myeloid malignancies. However, its specific role in RAS mutant-induced myeloid malignancy is incompletely understood. In this study, we found that m6A methyltransferase METTL14 was highly expressed and associated with a shorter survival in a RAS-mutant myeloid malignancy, juvenile myelomonocytic leukemia (JMML). The knockout of METTL14 was revealed to significantly promote hematopoietic stem/progenitor cells (HSPCs) expansion and suppresses disease progression in a KrasG12D/+ mutant-induced mouse model of JMML. Moreover, knockout of METTL14 reduces hyperproliferation of KrasG12D/+ HSPCs and suppresses oncogenic KrasG12D/+-induced myeloid disease in a cell-autonomous manner. Mechanistically, we revealed that the knockout of METTL14 reduced the autophagy levels of HSPCs by suppressing the transcription and translation of autophagy-related genes, such as Atg5 and Atg9a, through m6A modification. Furthermore, we found that the autophagy inhibition through knockout of ATG5 in Kras mutant mice promoted the expansion of HSPCs and inhibited the progression of leukemia disease, consistent with the phenotypes of knockout of METTL14. Finally, we observed that combined treatment with an m6A inhibitor and a MEK inhibitor synergistically suppressed JMML growth. Collectively, these findings highlight the critical role of METTL14 in JMML tumorigenesis and suggest that m6A RNA modification represents a promising therapeutic target for this disease.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298134">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE285346 çº¿ç²’ä½“ä»£è°¢å’Œä¿¡å·ä¼ å¯¼ç›´æ¥è°ƒæ§æ ‘çªçŠ¶ç»†èƒåœ¨æŠ—è‚¿ç˜¤å…ç–«ä¸­çš„åŠŸèƒ½</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€dendritic cellã€metabolism</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by array ; Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusThis SuperSeries is composed of the SubSeries listed below.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285346">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE302362 çº³ç±³é¢—ç²’è¯±å¯¼æŠ—åŸå‘ˆé€’å•æ ¸ç»†èƒæ¥æºçš„æ ‘çªçŠ¶ç»†èƒå¯æŠ‘åˆ¶è½¬ç§»å¹¶ç¼“è§£è½¬ç§»å¾®ç¯å¢ƒä¸­çš„å…ç–«æŠ‘åˆ¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmonocyteã€antigenã€regex:immuno(logy|therapy|suppression)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jeffrey A Ma ; Kate V Griffin ; Kathryn Kang ; Agustina Diener ; Ian A Schrack ; Elizabeth J Bealer ; Laila M Rad ; Rebecca S Pereles ; Jacqueline S Jeruss ; Lonnie D SheaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusMyeloid immune cells play a major role in establishing a suitable microenvironment for metastatic tumor cells. Dysregulated myeloid cells suppress antigen-presentation pathways and effector T cell responses at distal organs, and reprogramming these cells may enhance anti-tumor cytotoxicity. Targeting myeloid cells with poly(lactide-co-glycolide) nanoparticles, which possess intrinsic immunomodulatory properties, can promote monocyte maturation to inhibit metastasis. Intravenously delivered nanoparticles made with polyvinyl alcohol, but not other surfactants, reduce the accumulation of neutrophils at the metastatic niche and induce the differentiation of monocytes into antigen-presenting monocyte-derived dendritic cells. The internalization of nanoparticles was linked to the upregulation of gene expression programs in monocyte-derived dendritic cells associated with antigen presentation and T cell stimulation, and ligand-receptor network modeling supports increased activation of Th1 cells by these monocyte-derived dendritic cells. Nanoparticle administration increased the proportion of CD4 cells with Th1 and Th17 phenotypes and did not inhibit metastasis in mice where monocytes or T cells were depleted, indicating that interactions between monocyte-derived dendritic cells and T cells are essential to the mechanism of action. Collectively, our findings demonstrate that nanoparticles can reprogram circulating monocytes into monocyte-derived dendritic cells to modulate the metastatic niche and enhance antigen presentation to stimulate intrinsic T cell responses.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302362">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> <strong>GSE313170 ç ”ç©¶æ¬¡é»„ç´ åŒ–é€”å¾„åœ¨å‰åˆ—è…ºç™Œè¿›å±•ä¸­çš„ä½œç”¨</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€pathway</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Michel Kahi ; Anne Vincent ; JeanJacques Diaz ; Frederic BostSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensWe studied the involvement of the hypusination pathway in prostate cancer progression using various models, including patient-derived tumor organoid cell lines and in vivo mouse models. We employed different omics techniques to identify the molecular mechanisms linking hypusination to the aggressiveness of prostate cancer.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313170">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>GSE306252 é€šè¿‡mRNAæµ‹åºé‰´å®šè‚ç»†èƒç™Œä¸­çš„è¯Šæ–­æ€§å¤–æ³Œä½“miRNAå’Œè‡´ç—…è°ƒæ§ç½‘ç»œ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcarcinomaã€sequencing</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xiao Jingwen ; Ma Shiyue ; Tan Qiupei ; Xiao Jianlong ; Liu Shanshan ; Shi Qingfeng ; Yang JunSeries Type : Non-coding RNA profiling by high throughput sequencingOrganism : Homo sapiensBackground/Objectives: Hepatocellular carcinoma (HCC) is the sixth most common malignancy worldwide and the third leading cause of cancer-related mortality. Prognosis is stage-dependent, but most patients are diagnosed at advanced stages when curative treatment is not feasible. Alpha-fetoprotein (AFP), the most widely used biomarker, has limited sensitivity and specificity for early detection. Serum-derived exosomal mi-croRNAs (miRNAs) are stable in circulation, tumor-specific, and actively involved in cancer biology, making them promising non-invasive biomarkers. This study aimed to identify, validate, and functionally characterize serum-derived exosomal miRNAs with diagnostic potential in HCC. Methods: Serum exosomes were isolated from 50 HCC pa-tients and 50 matched healthy controls, characterized by transmission electron micros-copy, nanoparticle tracking analysis, and CD9/CD63/CD81 flow cytometry. High-throughput small RNA sequencing of 3 HCC and 3 control samples identified dif-ferentially expressed miRNAs (DEMs). Target genes were predicted via multiple data-bases, integrated into STRING proteinâ€“protein interaction networks, and analyzed with cytoHubba. Gene Ontology (GO) and KEGG enrichment analyses were performed. Hub gene expression and survival relevance were evaluated using GEPIA2. Candidate miRNAs were validated by RT-qPCR, and diagnostic performance was assessed with receiver operating characteristic (ROC) analysis. Results: Seven DEMs were identified; FOXO1 and SRSF11 emerged as hub genes. hsa-miR-27a-3p targeted FOXO1, and hsa-miR-493-3p targeted SRSF11. RT-qPCR confirmed hsa-miR-27a-3p upregulation (P = 0.003) and hsa-miR-493-3p downregulation (P = 0.014) in HCC exosomes. ROC analysis showed high diagnostic accuracy for hsa-miR-493-3p (AUC = 0.840) and hsa-miR-27a-3p (AUC = 0.827), comparable to AFP (AUC = 0.828), with improved performance when combined. Conclusions: Serum-derived exosomal hsa-miR-27a-3p and hsa-miR-493-3p are promising non-invasive biomarkers for HCC, with diagnostic value comparable to AFP and mechanistic links to FOXO1 and SRSF11. Their integration into miRNA-based panels may improve early detection.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306252">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>GSE285347 IgAè‚¾ç—…è¡¨è§‚é—ä¼ ç”Ÿç‰©æ ‡å¿—ç‰©çš„å‘ç°ï¼šåˆ©ç”¨ATAC-Seqåˆ†æå¾ªç¯CD8+ Tç»†èƒçš„æŸ“è‰²è´¨å¼€æ”¾æ€§</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šATAC-seqã€epigenetic</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Gwanghun Kim ; Soojin Lee ; Ik Soo Kim ; Hyun Mu Shin ; Hang-Rae Kim ; Dong Ki KimSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensChromatin openess plays a critical role in understanding epigenetic regulation in disease states. Using ATAC-seq, we profiled circulating CD8+ T cells from IgA nephropathy (IgAN) patients to identify biomarkers distinguishing early and late disease stages. A total of 279 differential ATAC peaks were identified, with 122 selected as biomarkers based on fold change (>2) and statistical significance (P &lt; 0.05). These biomarkers exhibited distinct chromatin accessibility patterns, highlighting differential regulatory mechanisms. Combining multiple biomarkers through weighted scoring enhanced predictive accuracy, with ROC analysis confirming their diagnostic potential. Our findings demonstrate that chromatin openness in circulating CD8+ T cells provides valuable insights into disease progression and serves as a robust platform for biomarker discovery in IgAN.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285347">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>GSE277903 Î³Î´ T ç»†èƒçš„å…ˆå¤©ç»„ç»‡å…ç–«ç›‘è§†å¯¹ T ç»†èƒå—ä½“å…·æœ‰å®æ—¶ä¾èµ–æ€§ [RNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šT cellã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Miguel Munoz-Ruiz ; Nicolas Veland ; Adrian HaydaySeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusWith clonotypic potential to engage different ligands, T cell receptor (TCR) Î³Î´ fulfils a key tenet of adaptive immunity. Nonetheless, many Î³Î´ repertoires are non-circulating, display limited diversity, and are commonly classified as innate-like, questioning any requirement for the TCR beyond the cellsâ€™ development. Addressing this long-standing issue, we now show that the steady-state phenotypes of different tissue-intrinsic Î³Î´ T cell compartments share a dependence on constitutive TCR expression. Deprived of this, cells rapidly become dysregulated, losing their capacity to respond to wide-ranging tissue insults, including imiquimod, an innate inducer of psoriasis-like pathology, u.v. irradiation, and melanoma. Thus, beyond any developmental requirements, the TCR is required in real time to regulate the cellsâ€™ innate-like tissue immunosurveillance. Biologically, this clearly distinguishes intrinsic Î³Î´ T cells from NK and other innate lymphoid cells, while clinically it stresses the importance of the TCR in delivering gd T cell-based immunotherapies.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277903">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>GSE277902 Î³Î´ T ç»†èƒçš„å…ˆå¤©ç»„ç»‡å…ç–«ç›‘è§†å¯¹ T ç»†èƒå—ä½“å…·æœ‰å®æ—¶ä¾èµ–æ€§ [ATAC-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šT cellã€ATAC-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Miguel Munoz-Ruiz ; Nicolas Veland ; Adrian HaydaySeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusWith clonotypic potential to engage different ligands, T cell receptor (TCR) Î³Î´ fulfils a key tenet of adaptive immunity. Nonetheless, many Î³Î´ repertoires are non-circulating, display limited diversity, and are commonly classified as innate-like, questioning any requirement for the TCR beyond the cellsâ€™ development. Addressing this long-standing issue, we now show that the steady-state phenotypes of different tissue-intrinsic Î³Î´ T cell compartments share a dependence on constitutive TCR expression. Deprived of this, cells rapidly become dysregulated, losing their capacity to respond to wide-ranging tissue insults, including imiquimod, an innate inducer of psoriasis-like pathology, u.v. irradiation, and melanoma. Thus, beyond any developmental requirements, the TCR is required in real time to regulate the cellsâ€™ innate-like tissue immunosurveillance. Biologically, this clearly distinguishes intrinsic Î³Î´ T cells from NK and other innate lymphoid cells, while clinically it stresses the importance of the TCR in delivering gd T cell-based immunotherapies.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277902">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 66 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>RNA-seq</td><td>16</td></tr><tr><td>cancer</td><td>8</td></tr><tr><td>T cell</td><td>7</td></tr><tr><td>tumor</td><td>7</td></tr><tr><td>genome</td><td>6</td></tr><tr><td>ATAC-seq</td><td>6</td></tr><tr><td>carcinoma</td><td>5</td></tr><tr><td>scRNA</td><td>5</td></tr><tr><td>regex:onco(logy</td><td>logist</td></tr><tr><td>sequencing</td><td>4</td></tr><tr><td>aging</td><td>4</td></tr><tr><td>ChIP-seq</td><td>4</td></tr><tr><td>immune</td><td>3</td></tr><tr><td>pathway</td><td>2</td></tr><tr><td>single-cell</td><td>2</td></tr><tr><td>transcriptome</td><td>2</td></tr><tr><td>inflammation</td><td>2</td></tr><tr><td>metabolism</td><td>2</td></tr><tr><td>leukemia</td><td>2</td></tr><tr><td>KRAS</td><td>2</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (66æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272538">GSE272538 EZH2 å’Œ E2F1 çš„æ–°å…³è”é€šè¿‡æŸ“è‰²è´¨é‡å¡‘ä¿ƒè¿›ä¹³è…ºç™Œç»†èƒå¢æ®– [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272537">GSE272537 EZH2 å’Œ E2F1 çš„æ–°å…³è”é€šè¿‡æŸ“è‰²è´¨é‡å¡‘ä¿ƒè¿›ä¹³è…ºç™Œç»†èƒå¢æ®– [CHIP-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272536">GSE272536 EZH2 å’Œ E2F1 çš„æ–°å…³è”é€šè¿‡æŸ“è‰²è´¨é‡å¡‘ä¿ƒè¿›ä¹³è…ºç™Œç»†èƒå¢æ®– [ATAC-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305891">GSE305891 ATF4 çš„åŸºç¡€æ°´å¹³ä¿ƒè¿› T ç»†èƒæ´»åŒ–è¯±å¯¼å¢æ®–çš„å‡†å¤‡çŠ¶æ€ [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288143">GSE288143 ATF4 åŸºç¡€æ°´å¹³ä¿ƒè¿› T ç»†èƒæ´»åŒ–è¯±å¯¼å¢æ®–çš„å‡†å¤‡çŠ¶æ€ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288073">GSE288073 ARTS é€šè¿‡ Livin-MDM2-p53 é€šè·¯è¯±å¯¼å‡‹äº¡ä¾èµ–æ€§è‡ªå™¬ï¼Œä»è€Œèµ‹äºˆä¹³è…ºç™Œç»†èƒåŒ–ç–—è€è¯æ€§ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283719">GSE283719 EGR1ä¾èµ–çº§è”è°ƒèŠ‚CSF1RåŸºå› åº§çš„åŸºå› ç»„ç»“æ„[Hi-C]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283718">GSE283718 EGR1ä¾èµ–çº§è”è°ƒèŠ‚CSF1RåŸºå› åº§çš„åŸºå› ç»„ç»“æ„[ChIP-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283663">GSE283663 EGR1ä¾èµ–çº§è”è°ƒèŠ‚CSF1RåŸºå› åº§çš„åŸºå› ç»„ç»“æ„[RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255626">GSE255626 åŸå‘æ€§èƒ¶è´¨æ¯ç»†èƒç˜¤æ‚£è€…ç»„ç»‡çš„ä¸‹ä¸€ä»£æµ‹åºï¼ˆæ€»RNAæµ‹åºï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE208745">GSE208745 è‚¿ç˜¤ç‰¹å¼‚æ€§lncRNA IGF1R-AS1åå¼è°ƒæ§ä¸è‡´ç™ŒMYCä¿¡å·ç›¸å…³çš„æŸ“è‰²è´¨ç›¸äº’ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298483">GSE298483 è¯±å¯¼è‚¾è„å‘è‚²ç»†èƒçŠ¶æ€ä¸é¢„åè‰¯å¥½å‹è‚¾æ¯ç»†èƒç˜¤çš„åŒ–ç–—è€è¯æ€§ç›¸å…³</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230838">GSE230838 è‚è„ä¸­é¡ºå¼ç£·é…¸è½¬ç§»é…¶åŠŸèƒ½çš„ä¸§å¤±ä¿ƒè¿›äº†ä¸€ç§é«˜å¤–æ˜¾ç‡çš„è„‚è‚ªè‚ç–¾ç—…ï¼Œè¯¥ç–¾ç—…è¿…é€Ÿè½¬å˜ä¸ºè‚ç»†èƒç™Œ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230616">GSE230616 è‚è„ä¸­é¡ºå¼ç£·é…¸è½¬ç§»é…¶åŠŸèƒ½çš„ä¸§å¤±ä¿ƒè¿›äº†ä¸€ç§é«˜å¤–æ˜¾ç‡çš„è„‚è‚ªè‚ç–¾ç—…ï¼Œè¯¥ç–¾ç—…è¿…é€Ÿè½¬å˜ä¸ºè‚ç»†èƒç™Œ [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289395">GSE289395 pTÎ± å¢å¼º mRNA ç¿»è¯‘å¹¶å¢å¼º CAR T ç»†èƒå¯¹å®ä½“ç˜¤çš„æ ¹é™¤ä½œç”¨ [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289390">GSE289390 pTÎ± å¢å¼º mRNA ç¿»è¯‘å¹¶å¢å¼º CAR T ç»†èƒå¯¹å®ä½“ç˜¤çš„æ ¹é™¤ä½œç”¨ [æ‰¹é‡ RNA æµ‹åº]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315268">GSE315268 é«˜èƒ½è„‰å†²ç”µå­æŸ (HEPE) è¯±å¯¼é“¾éœ‰èŒ lividans 1326 èŒæ ªåŸºå› è¡¨è¾¾çš„å…¨åŸºå› ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299892">GSE299892 MSC-exo å¤„ç†çš„ HUVEC çš„è½¬å½•ç»„åˆ†æç ”ç©¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299879">GSE299879 N-ä¹™é…°-L-åŠèƒ±æ°¨é…¸ä¹™é…¯ (NACET) å¯è¯±å¯¼è§†ç½‘è†œä¸­çš„è½¬å½•å› å­ NRF2ï¼Œå¹¶é˜²æ­¢è§†ç½‘è†œè€åŒ–å’Œç³–å°¿ç—…è§†ç½‘è†œç—…å˜ã€‚[IV]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299877">GSE299877 N-ä¹™é…°-L-åŠèƒ±æ°¨é…¸ä¹™é…¯ (NACET) å¯è¯±å¯¼è§†ç½‘è†œä¸­çš„è½¬å½•å› å­ NRF2ï¼Œå¹¶é˜²æ­¢è§†ç½‘è†œè€åŒ–å’Œç³–å°¿ç—…è§†ç½‘è†œç—…å˜ã€‚[III]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299876">GSE299876 N-ä¹™é…°-L-åŠèƒ±æ°¨é…¸ä¹™é…¯ (NACET) å¯è¯±å¯¼è§†ç½‘è†œä¸­çš„è½¬å½•å› å­ NRF2ï¼Œå¹¶é˜²æ­¢è§†ç½‘è†œè€åŒ–å’Œç³–å°¿ç—…è§†ç½‘è†œç—…å˜ã€‚[II]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299875">GSE299875 N-ä¹™é…°-L-åŠèƒ±æ°¨é…¸ä¹™é…¯ (NACET) å¯è¯±å¯¼è§†ç½‘è†œä¸­è½¬å½•å› å­ NRF2 çš„è¡¨è¾¾ï¼Œå¹¶é¢„é˜²è§†ç½‘è†œè¡°è€å’Œç³–å°¿ç—…è§†ç½‘è†œç—…å˜ã€‚[I]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297705">GSE297705 ç”²åŸºçº¢æ†èŒ AM1 é‡ç”Ÿå‹å’Œç”²é†‡é€‚åº”èŒæ ªçš„ RNA-seq æ•°æ® [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294020">GSE294020 U2AF2 ç¼ºé™·å¯¹åµå·¢ç™Œç»†èƒåŸºå› è¡¨è¾¾çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293681">GSE293681 é¶å‘é•¿é“¾éç¼–ç RNA lnc-Megaclusterå¯¹è‚¥èƒ–ç—‡çš„ä»£è°¢æœ‰ç›Šä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290701">GSE290701 æŠ—æ°§åŒ–çº³ç±³æŠ€æœ¯ä»‹å¯¼çš„å¤ªç©ºç¥ç»å…ƒæŸä¼¤é˜²æŠ¤ï¼ˆPROMETEOï¼ŒæŠ—æ°§åŒ–ä¿æŠ¤ï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289379">GSE289379 DNAç”²åŸºåŒ–å¯é¢„æµ‹å›Šæ€§çº¤ç»´åŒ–æ‚£è€…ç—°æ¶²æ ·æœ¬ä¸­çš„è‚ºåŠŸèƒ½å’Œè‚ºéƒ¨æ€¥æ€§åŠ é‡æƒ…å†µ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285335">GSE285335 IgANæ‚£è€…å¤–å‘¨è¡€å•æ ¸ç»†èƒçš„å•ç»†èƒè½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285114">GSE285114 LOXL2 ç¼ºå¤±åœ¨åˆ›ä¼¤åæŸä¼¤ä¸­ä¼šæ‰°ä¹±è†å…³èŠ‚ç¨³æ€ï¼Œå¹¶ä¿ƒè¿›ç–¼ç—›æ•æ„Ÿæ€§ã€ç‚ç—‡å’Œéª¨å…³èŠ‚ç‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE262416">GSE262416 ç¾ä¸¸é—´è´¨ç»¼åˆå›¾è°±æ­ç¤º Cd34+/Sox4+ é—´å……è´¨ç»†èƒæ˜¯æ½œåœ¨çš„ Leydig ç»†èƒç¥–ç»†èƒ [scRNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE247323">GSE247323 æ¯ä½“è¡¥å……å²å“šå¯é€šè¿‡æ”¹å˜è‚ é“èŒç¾¤å’ŒèŠ³çƒƒå—ä½“ä»‹å¯¼çš„ç¥ç»é…°èƒºä»£è°¢æ¥ä¿æŠ¤åä»£å…å—éé…’ç²¾æ€§è„‚è‚ªæ€§è‚ç—… (NAFLD) çš„ä¾µå®³</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316529">GSE316529 JAK1 åŠŸèƒ½ä¸§å¤±å¯¼è‡´ G2/M ç»†èƒå‘¨æœŸç¼ºé™·ï¼Œæ˜“å— KIF18A æŠ‘åˆ¶çš„å½±å“ [Detroit562 RNAseq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312457">GSE312457 RNA-Seq æ•°æ®æ¥è‡ª Pdgfra-Cre ä»‹å¯¼çš„ Esr1 æ¡ä»¶æ€§æ•²é™¤å°é¼ çš„è¾“åµç®¡åŸºè´¨ç»†èƒ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310469">GSE310469 RNA-seq æ•°æ®ç”¨äºç ”ç©¶è¾“åµç®¡é—´è´¨ç»†èƒå’Œ/æˆ–é›Œæ¿€ç´ æ²»ç–—å¯¹è¾“åµç®¡ä¸Šçš®ç»†èƒçš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307602">GSE307602 DKK3 æœ€åˆé€šè¿‡ MEK-Fos ä¿¡å·é€šè·¯ç»´æŒè…ºæ³¡å®Œæ•´æ€§ï¼Œä½†éšååœ¨èƒ°è…ºå¯¼ç®¡è…ºç™Œä¸­è½¬å˜ä¸ºè‡´ç™Œä½œç”¨ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306878">GSE306878 è‚¿ç˜¤æŠ‘åˆ¶å› å­RESTå¯¹é›Œæ¿€ç´ å—ä½“ï¼ˆESR1ï¼‰è¡¨è¾¾å’Œå­å®«è‚Œç˜¤ç—…ç†ç”Ÿç†å­¦çš„è°ƒæ§ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305975">GSE305975 ATF4 çš„åŸºç¡€æ°´å¹³ä¿ƒè¿› T ç»†èƒæ´»åŒ–è¯±å¯¼å¢æ®–çš„å‡†å¤‡çŠ¶æ€</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305890">GSE305890 ATF4 çš„åŸºç¡€æ°´å¹³ä¿ƒè¿› T ç»†èƒæ´»åŒ–è¯±å¯¼å¢æ®–çš„å‡†å¤‡çŠ¶æ€ [CUT&amp;Run]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303595">GSE303595 Leo1 ç¼ºå¤±æ­ç¤º Set1 ä¾èµ–æ€§è½¬å½•æ¿€æ´» [ChIP-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298999">GSE298999 ANCAç›¸å…³æ€§è¡€ç®¡ç‚ä¸­å…ç–«ç›¸å…³åŸºå› çš„è‚¾è„è½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298852">GSE298852 NSMF å‡è½»è¿‡åº¦å¤åˆ¶å‹åŠ›ä»¥ä¿ƒè¿›ç»“ç›´è‚ ç™Œè¿›å±•</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298293">èƒ¸è…º iNKT ç»†èƒçš„ GSE298293 å•ç»†èƒ RNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298292">GSE298292 å…¨èƒ¸è…ºç»†èƒå’Œçº¯åŒ–çš„ CD4+CD8+TCRlow DP èƒ¸è…ºç»†èƒçš„ RNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298291">GSE298291 DPèƒ¸è…ºç»†èƒçš„ATAC-seq</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297499">GSE297499ï¼šæ‚£æœ‰ç¥ç»ç²¾ç¥æ€§é•¿æ–°å† çš„å¥³æ€§è„‘è„Šæ¶²å…ç–«ç»†èƒæ”¹å˜</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297480">GSE297480 BRG1/BRM æŠ‘åˆ¶å‰‚ä¸ BET æŠ‘åˆ¶å‰‚æˆ–åœ°è¥¿ä»–æ»¨è”åˆæ²»ç–—é«˜å± MECOM é‡æ’ AML çš„é«˜æ•ˆç–—æ•ˆ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297477">GSE297477 BRG1/BRM æŠ‘åˆ¶å‰‚ä¸ BET æŠ‘åˆ¶å‰‚æˆ–åœ°è¥¿ä»–æ»¨è”åˆæ²»ç–—é«˜å± MECOM é‡æ’ AML çš„é«˜æ•ˆç–—æ•ˆ [ChIP-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297475">GSE297475 BRG1/BRM æŠ‘åˆ¶å‰‚ä¸ BET æŠ‘åˆ¶å‰‚æˆ–åœ°è¥¿ä»–æ»¨è”åˆæ²»ç–—é«˜å± MECOM é‡æ’ AML çš„é«˜æ•ˆç–—æ•ˆ [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296003">GSE296003 ç»„è›‹ç™½3èµ–æ°¨é…¸56ä¹™é…°åŒ–ï¼ˆH3K56acï¼‰è°ƒæ§æŸ“è‰²ä½“å¤–DNAï¼ˆecDNAï¼‰æ¢çº½çš„ç”Ÿç‰©åˆæˆ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293519">GSE293519 é›„æ¿€ç´ ä¿¡å·åœ¨ 2 å‹å›ºæœ‰æ·‹å·´ç»†èƒä¸­é©±åŠ¨å¹½é—¨èºæ†èŒæ„ŸæŸ“å¼•èµ·çš„èƒƒç‚ç—‡å’Œèç¼©çš„æ€§åˆ«å·®å¼‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283672">GSE283672 EGR1ä¾èµ–çº§è”è°ƒèŠ‚CSF1RåŸºå› åº§çš„åŸºå› ç»„ç»“æ„[CUT&amp;Run]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283670">GSE283670 EGR1ä¾èµ–çº§è”è°ƒèŠ‚CSF1RåŸºå› åº§çš„åŸºå› ç»„ç»“æ„[Capture-C]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283238">GSE283238 DKK3 æœ€åˆé€šè¿‡ MEK-Fos ä¿¡å·ä¼ å¯¼æ¥ç»´æŒè…ºæ³¡å®Œæ•´æ€§ï¼Œä½†åæ¥åœ¨ PDAC ä¸­è½¬å˜ä¸ºè‡´ç™Œä½œç”¨ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279659">GSE279659 CD40Lé¶å‘å·¥ç¨‹åŒ–è°ƒèŠ‚æ€§Tç»†èƒä½œä¸ºä¸€ç§æ²»ç–—Tç»†èƒä»‹å¯¼çš„ç‚ç—‡æ€§ç–¾ç—…çš„æ–°å‹ç»†èƒç–—æ³•</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315410">GSE315410 è‚è„ä¸­é¡ºå¼ç£·é…¸è½¬ç§»é…¶åŠŸèƒ½çš„ä¸§å¤±ä¿ƒè¿›äº†ä¸€ç§é«˜å¤–æ˜¾ç‡çš„è„‚è‚ªè‚ç–¾ç—…ï¼Œè¯¥ç–¾ç—…è¿…é€Ÿè½¬å˜ä¸ºè‚ç»†èƒç™Œ [RNAseq_ChowDiet_NgBR_Liver]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288778">GSE288778 MYRF æ§åˆ¶é—´çš®ç»†èƒåˆ†åŒ–ã€ä¿¡å·ä¼ å¯¼å’Œå¯å¡‘æ€§ [scRNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288777">GSE288777 MYRF æ§åˆ¶é—´çš®ç»†èƒåˆ†åŒ–ã€ä¿¡å·ä¼ å¯¼å’Œå¯å¡‘æ€§ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287422">GSE287422 MYCN å’Œ ALK å…±è¡¨è¾¾è¯±å¯¼äºº iPS ç»†èƒè¡ç”Ÿçš„é¢…ç¥ç»åµ´ç»†èƒå‘ç”Ÿç¥ç»æ¯ç»†èƒç˜¤æ ·è‚¿ç˜¤ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230972">GSE230972 ç ”ç©¶å‘ç°ï¼Œè‚è„ä¸­é¡ºå¼ç£·é…¸è½¬ç§»é…¶ï¼ˆcisPTaseï¼‰åŠŸèƒ½çš„ä¸§å¤±ä¼šä¿ƒè¿›ä¸€ç§é«˜å¤–æ˜¾ç‡çš„è„‚è‚ªè‚ç–¾ç—…çš„å‘ç”Ÿï¼Œè¯¥ç–¾ç—…ä¼šè¿…é€Ÿå‘å±•ä¸ºè‚ç»†èƒç™Œã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316672">GSE316672 åˆ©ç”¨ GeoMx DSP å¯¹ç»†æ”¯æ°”ç®¡è¿›è¡Œç©ºé—´è½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316596">åˆ©ç”¨å•å…‹ç½—ä»–æ—ï¼ˆMCTï¼‰è¯±å¯¼çš„è‚ºåŠ¨è„‰é«˜å‹ï¼ˆPHï¼‰å¤§é¼ æ¨¡å‹ï¼Œé€šè¿‡RNAæµ‹åºåˆ†æé‰´å®šäº†å³å¿ƒæˆ¿ç»„ç»‡ä¸­çš„åŸºå› è¡¨è¾¾å˜åŒ–ï¼ˆGSE316596ï¼‰ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308540">GSE308540 RORÎ³é€šè¿‡ä¸Šè°ƒNGFä¿¡å·é€šè·¯é©±åŠ¨éå°ç»†èƒè‚ºç™Œè¿›å±•</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304796">GSE304796 pTÎ± å¢å¼º mRNA ç¿»è¯‘å¹¶å¢å¼º CAR T ç»†èƒå¯¹å®ä½“ç˜¤çš„æ ¹é™¤ä½œç”¨ [Ribo-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304795">GSE304795 pTÎ± å¢å¼º mRNA ç¿»è¯‘å¹¶å¢å¼º CAR T ç»†èƒå¯¹å®ä½“ç˜¤çš„æ ¹é™¤ä½œç”¨ [eCLIP-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302228">GSE302228 ä¸‹ä¸€ä»£æµ‹åºæœ‰åŠ©äºå¯¹ç»åŒ–åˆç‰© 20 å¤„ç†æˆ–æœªå¤„ç†çš„ç™½è‰²å¿µç èŒ SC5314 è¿›è¡Œè½¬å½•è°±å®šé‡åˆ†æã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248722">GSE248722 Cyfip2 æ•²é™¤å°é¼ å‰è„‘å•ç»†èƒè½¬å½•ç»„åˆ†æ</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-01-22 21:43</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week042026/ rel=tag>Week042026</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2026-01-22/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-22</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2026-01-24/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-24</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-09/>ç§‘ç ”æ—¥æŠ¥ 2026-02-09</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-08/>ç§‘ç ”æ—¥æŠ¥ 2026-02-08</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-07/>ç§‘ç ”æ—¥æŠ¥ 2026-02-07</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-06/>ç§‘ç ”æ—¥æŠ¥ 2026-02-06</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-05/>ç§‘ç ”æ—¥æŠ¥ 2026-02-05</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (102)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (102)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week062026/ title=Week062026>Week062026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>